230 related articles for article (PubMed ID: 6781341)
1. The pharmacology of sulfonylureas.
Skillman TG; Feldman JM
Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
[TBL] [Abstract][Full Text] [Related]
2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
3. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
[TBL] [Abstract][Full Text] [Related]
4. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
Lev JD; Zeidler A; Kumar D
Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
[TBL] [Abstract][Full Text] [Related]
5. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects.
Feldman JM
Pharmacotherapy; 1985; 5(2):43-62. PubMed ID: 3923453
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of glipizide.
Melander A; Wåhlin-Boll E
Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment in diabetes.
Stowers JM
Clin Endocrinol Metab; 1972 Nov; 1(3):721-50. PubMed ID: 4204135
[No Abstract] [Full Text] [Related]
8. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
9. Oral sulfonylureas for the treatment of type II diabetes: an update.
Shank WA; Morrison AD
South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
[TBL] [Abstract][Full Text] [Related]
10. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
SMITH DL; VECCHIO TJ; FORIST AA
Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
[No Abstract] [Full Text] [Related]
11. Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Jannetto PJ; Langman LJ
Methods Mol Biol; 2024; 2737():297-306. PubMed ID: 38036831
[TBL] [Abstract][Full Text] [Related]
12. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Balant L
Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
[No Abstract] [Full Text] [Related]
13. Oral hypoglycemic agents in the treatment of type II diabetes.
Tal A
Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
[TBL] [Abstract][Full Text] [Related]
14. Are the 'second generation' oral hypoglycemic agents really different?
Pfeiffer EF
Acta Diabetol Lat; 1984; 21(1):1-32. PubMed ID: 6428111
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the sulfonylurea receptor on beta cell membranes.
Gaines KL; Hamilton S; Boyd AE
J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of sulfonylureas.
Melander A
Metabolism; 1987 Feb; 36(2 Suppl 1):12-6. PubMed ID: 3543616
[TBL] [Abstract][Full Text] [Related]
17. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Lebovitz HE
Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
[TBL] [Abstract][Full Text] [Related]
18. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
19. Kinetics-effect relations of glipizide and other sulfonylureas.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Endocrinol Suppl (Copenh); 1980; 239():3-5. PubMed ID: 6776762
[TBL] [Abstract][Full Text] [Related]
20. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
